ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,726, issued on Oct. 14, was assigned to Foghorn Therapeutics Inc. (Cambridge, Mass.).
"Compounds and uses thereof" was invented by Kevin J. Wilson (Roslindale, Mass.), Shawn E. R. Schiller (Haverhill, Mass.) and Solymar Negretti (Watertown, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure features compounds useful for the treatment of BAF complex-related disorders."
The patent was filed on Jan. 29, 2021, under Application No. 17/795,778.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&...